HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malini Olivo Selected Research

Cetuximab (Erbitux)

9/2011Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
11/2009Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Malini Olivo Research Topics

Disease

72Neoplasms (Cancer)
01/2022 - 01/2002
18Urinary Bladder Neoplasms (Bladder Cancer)
12/2014 - 02/2003
14Carcinoma (Carcinomatosis)
09/2012 - 01/2002
12Nasopharyngeal Carcinoma
10/2007 - 03/2002
8Breast Neoplasms (Breast Cancer)
01/2024 - 02/2014
8Necrosis
05/2010 - 05/2003
7Hypoxia (Hypoxemia)
09/2011 - 12/2005
7Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
12/2006 - 07/2002
6Phototoxic Dermatitis (Phototoxicity)
08/2008 - 09/2002
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2014 - 01/2002
3Lung Neoplasms (Lung Cancer)
10/2022 - 03/2007
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2015
3Hyperthermia
10/2021 - 01/2008
3Mouth Neoplasms (Oral Cancer)
07/2011 - 01/2002
3Hemangiosarcoma (Angiosarcoma)
08/2008 - 10/2007
3Photosensitivity Disorders (Photodermatitis)
12/2007 - 06/2002
2Psoriasis (Pustulosis Palmaris et Plantaris)
08/2024 - 08/2023
2Atopic Dermatitis (Atopic Eczema)
06/2022 - 01/2019
2Ovarian Epithelial Carcinoma
01/2022 - 01/2019
2Wounds and Injuries (Trauma)
01/2021 - 01/2019
2Ovarian Cysts (Ovarian Cyst)
01/2020 - 01/2019
2Glioblastoma (Glioblastoma Multiforme)
10/2018 - 01/2016
2Neoplasm Metastasis (Metastasis)
02/2015 - 05/2010
1Ischemia
03/2024
1Peripheral Arterial Disease
03/2024
1Cardiovascular Diseases (Cardiovascular Disease)
11/2023
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
06/2021
1Vascular Diseases (Vascular Disease)
06/2021
1Margins of Excision
01/2021

Drug/Important Bio-Agent (IBA)

361-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2014 - 03/2002
25hypericinIBA
09/2012 - 05/2002
24Photosensitizing Agents (Photosensitizers)IBA
02/2015 - 01/2002
13Biomarkers (Surrogate Marker)IBA
01/2024 - 02/2014
11protoporphyrin IXIBA
01/2007 - 01/2002
8AcidsIBA
02/2015 - 01/2002
8phytochlorinIBA
10/2011 - 06/2005
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2011 - 12/2005
7Oxygen (Dioxygen)IBA
05/2010 - 01/2006
6Proteins (Proteins, Gene)FDA Link
11/2023 - 12/2002
6Povidone (Crospovidone)IBA
01/2009 - 08/2006
4HaptoglobinsIBA
01/2022 - 01/2015
4Contrast MediaIBA
02/2015 - 09/2009
4GoldIBA
01/2014 - 04/2009
4Messenger RNA (mRNA)IBA
09/2012 - 03/2004
4Reactive Oxygen Species (Oxygen Radicals)IBA
05/2010 - 11/2003
4Angiogenesis InhibitorsIBA
11/2009 - 12/2005
4hypocrellin AIBA
01/2006 - 01/2002
3MicroRNAs (MicroRNA)IBA
01/2024 - 11/2021
3Hemoglobins (Hemoglobin)IBA
06/2021 - 10/2018
3LipidsIBA
09/2020 - 01/2002
3Bevacizumab (Avastin)FDA Link
09/2011 - 12/2007
3chlorophyllin (copper chlorophyll)IBA
12/2010 - 08/2006
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2008 - 10/2007
3CytokinesIBA
12/2007 - 07/2002
3N-methylpyrrolidoneIBA
10/2007 - 07/2006
3CaspasesIBA
03/2007 - 01/2002
3EstersIBA
10/2006 - 02/2003
3DNA (Deoxyribonucleic Acid)IBA
11/2005 - 01/2002
3hypocrellin BIBA
09/2004 - 01/2002
2RNA (Ribonucleic Acid)IBA
01/2024 - 11/2009
2CeramidesIBA
08/2023 - 04/2020
2SilverIBA
10/2022 - 01/2016
2Fluorescent Dyes (Fluorescent Probes)IBA
01/2019 - 01/2007
2fosbretabulin (combretastatin A4)IBA
10/2018 - 10/2018
2PolymersIBA
01/2015 - 08/2008
2ErbB Receptors (EGF Receptor)IBA
11/2014 - 11/2009
2Tumor Biomarkers (Tumor Markers)IBA
02/2014 - 03/2012
2SolutionsIBA
03/2012 - 08/2004
2Cetuximab (Erbitux)FDA Link
09/2011 - 11/2009
2chlorinIBA
01/2009 - 08/2006
2Angiogenic ProteinsIBA
06/2008 - 12/2007
2AlbuminsIBA
10/2007 - 03/2007
2Celecoxib (Celebrex)FDA Link
10/2007 - 12/2005
2SaltsIBA
11/2006 - 08/2006
2methylamphotericin B (AME)IBA
10/2006 - 02/2003
2PorphyrinsIBA
02/2003 - 11/2002
2Caspase 3 (Caspase-3)IBA
06/2002 - 03/2002
2Cytochromes c (Cytochrome c)IBA
06/2002 - 03/2002
1Adalimumab (Humira)FDA Link
08/2024
1SteroidsIBA
08/2024
1Troponin IIBA
11/2023
1ceramide 3IBA
08/2023
1CholesterolIBA
08/2023
1SiliconIBA
10/2022
1AntigensIBA
01/2022
1IntegrinsIBA
12/2021
1arginyl-glycyl-aspartic acidIBA
12/2021
1Circulating MicroRNAIBA
11/2021
1Coloring Agents (Dyes)IBA
01/2021
1CelluloseIBA
01/2021

Therapy/Procedure

31Photochemotherapy (Photodynamic Therapy)
09/2011 - 01/2002
13Therapeutics
10/2021 - 12/2005
12Lasers (Laser)
03/2017 - 03/2003
4Intravenous Administration
08/2008 - 11/2004
3Segmental Mastectomy (Lumpectomy)
01/2021 - 12/2018
2Photothermal Therapy
03/2017 - 02/2012
2Drug Therapy (Chemotherapy)
07/2009 - 12/2007
1Optical Devices
03/2024
1Optical Fibers
11/2023
1Mastectomy (Mammectomy)
01/2021